Literature DB >> 16442209

Prostate biopsy and optimization of cancer yield.

David G Bostwick, Isabelle Meiers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16442209     DOI： 10.1016/j.eururo.2005.12.052

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  10 in total

Review 1.  When prostate cancer remains undetectable: The dilemma.

Authors:  Mahmoud Othman Mustafa; Louis Pisters
Journal:  Turk J Urol       Date:  2015-03

2.  Transrectal Ultrasound Guided Biopsy of the Prostate: Is the Information Accessible, Usable, Reliable and Readable?

Authors:  Ciaran E Redmond; Gregory J Nason; Michael E Kelly; Colm McMahon; Colin P Cantwell; David M Quinlan
Journal:  Curr Urol       Date:  2015-05-20

3.  Utilization trends and positive biopsy rates for prostate biopsies in the United States: 2005 to 2011.

Authors:  Deepak A Kapoor; David G Bostwick; Savvas E Mendrinos; Ann E Anderson; Carl A Olsson
Journal:  Rev Urol       Date:  2013

4.  Pathological Correlation between Number of Biopsies and Radical Surgery: Does It Make a Difference to Final Pathology?

Authors:  Tahir Qayyum; Jennifer M Willder; Paul G Horgan; Joanne Edwards; Mark A Underwood
Journal:  Curr Urol       Date:  2013-07-28

Review 5.  The impact of prostate biopsy on urinary symptoms, erectile function, and anxiety.

Authors:  Alexander P Glaser; Kristian Novakovic; Brian T Helfand
Journal:  Curr Urol Rep       Date:  2012-12       Impact factor: 3.092

6.  Personalized prostate specific antigen testing using genetic variants may reduce unnecessary prostate biopsies.

Authors:  Brian T Helfand; Stacy Loeb; Qiaoyan Hu; Phillip R Cooper; Kimberly A Roehl; Barry B McGuire; Nikola A Baumann; William J Catalona
Journal:  J Urol       Date:  2013-02-27       Impact factor: 7.450

7.  Pathological correlation between needle biopsy and radical prostatectomy specimen in patients with localized prostate cancer.

Authors:  Muhammad A Bulbul; Yaser El-Hout; Maurice Haddad; Ayman Tawil; Ali Houjaij; Nizar Bou Diab; Oussama Darwish
Journal:  Can Urol Assoc J       Date:  2007-09       Impact factor: 1.862

8.  Local anesthesia type affects cancer detection rate in transrectal ultrasound guided prostate biopsy.

Authors:  Mustafa Zafer Temiz; Engin Kandirali; Aykut Colakerol; Murat Tuken; Atilla Semercioz
Journal:  Int Braz J Urol       Date:  2015 Sep-Oct       Impact factor: 1.541

9.  Cascaded discrimination of normal, abnormal, and confounder classes in histopathology: Gleason grading of prostate cancer.

Authors:  Scott Doyle; Michael D Feldman; Natalie Shih; John Tomaszewski; Anant Madabhushi
Journal:  BMC Bioinformatics       Date:  2012-10-30       Impact factor: 3.169

Review 10.  Focal low-dose rate brachytherapy for the treatment of prostate cancer.

Authors:  William Y Tong; Gilad Cohen; Yoshiya Yamada
Journal:  Cancer Manag Res       Date:  2013-09-13       Impact factor: 3.989
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.